Giardina W J, Ebert D M
Department of Pharmacology, Abbott Laboratories, Abbott Park, IL 60064.
Biol Psychiatry. 1989 Mar 15;25(6):697-702. doi: 10.1016/0006-3223(89)90240-0.
Captopril, an angiotensin II converting enzyme (ACE) inhibitor, was evaluated for potential antidepressive activity on the forced swim-induced behavioral despair (immobility) test in mice. Captopril (10.0 and 30.0, mg/kg ip) significantly reduced immobility and mimicked the effects of the antidepressants imipramine (30.0 mg/kg, ip) and mianserin (3.0, 10.0, and 30.0 mg/kg, ip). Captopril increased the motor activity of mice at these same dosages. Naloxone (2.0 mg/kg, ip) blocked the effects of captopril (30.0 mg/kg, ip) in the swim test. These data suggest that captopril has potential antidepressive activity. However, the conclusion is guarded, as the positive effects may be related to motor stimulation. The blockade of the captopril effects by naloxone suggests that brain opioid peptides play a role in this behavioral effect of captopril.
卡托普利是一种血管紧张素 II 转换酶(ACE)抑制剂,在小鼠强迫游泳诱导的行为绝望(不动)试验中对其潜在的抗抑郁活性进行了评估。卡托普利(10.0 和 30.0 毫克/千克,腹腔注射)显著减少了不动时间,并模拟了抗抑郁药丙咪嗪(30.0 毫克/千克,腹腔注射)和米安色林(3.0、10.0 和 30.0 毫克/千克,腹腔注射)的作用。卡托普利在这些相同剂量下增加了小鼠的运动活性。纳洛酮(2.0 毫克/千克,腹腔注射)在游泳试验中阻断了卡托普利(30.0 毫克/千克,腹腔注射)的作用。这些数据表明卡托普利具有潜在的抗抑郁活性。然而,由于其积极作用可能与运动刺激有关,因此结论较为谨慎。纳洛酮对卡托普利作用的阻断表明脑阿片肽在卡托普利的这种行为效应中起作用。